Search results
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 5 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 11 hours agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 5 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold | The Motley Fool
The Motley Fool· 12 hours agoInvestors looking for high-yield dividend stocks to buy now should turn their attention toward the...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 5 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19...
Marcum Wealth LLC Buys 3,926 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 9 hours agoMarcum Wealth LLC boosted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.8% during the first quarter, according to the company in its most recent filing ...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Pfizer CEO’s COVID-19 ‘rehearsal’ comment out of context
Politifact· 17 hours agoA Threads post took a year-old statement by Pfizer CEO Albert Bourla out of context to say the...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via AOL· 5 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...